Descrizione business
Medios AG, along with its subsidiaries Medios Pharma GmbH and Medios Manufaktur GmbH, has positioned itself in the specialty pharma segment as the go-to source for expertise and solutions. It brings together individual market players in a network of cooperating partners. Specialty pharmaceutical drugs are medications for patients with rare and/or chronic illnesses (for example, cancer, autoimmune diseases, and infectious diseases) that require lengthy and expensive treatment. Medios AG buys, sells and manages investments of innovative companies. The company aims to establish a strategic investment portfolio and to support its governance.
Consiglio di amministrazione & Consiglio di sorveglianza
| CEO |
| Matthias Gärtner |
| Consiglio di amministrazione |
| Falk Neukirch, Christoph Prußeit, Mi-Young Miehler |
| Consiglio di sorveglianza |
| Dr. Yann Samson, Joachim Messner, Dr. Anke Nestler, Klaus Buß |
Dati aziendali
| Name: |
Medios AG |
| Indirizzo: |
Friedrichstraße 113a,D-10117 Berlin |
| Telefono: |
+49-30-232-566-800 |
| Fax: |
+49-30-232-566-866 |
| E-mail: |
info@medios.ag
|
| Internet: |
www.medios.ag |
| Industria: |
Healthcare |
| Settore: |
Pharmaceutical Industry |
| Sub settore: |
Pharmaceuticals |
| Fine dell'anno finanziario: |
31/12 |
| Flottante libero: |
40.40% |
| Data dell'IPO: |
15/07/1999 |
Rapporti con gli investitori
| Name: |
- |
| IR telefono: |
- |
| IR Fax: |
- |
| IR e-mail: |
ir@medios.ag
|
